Owens Daniel E. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Owens Daniel E.
Chief HR Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-02$7.03/sh+3,750$26,355→ 14,450 total - Sale
Common Stock
2022-12-02$25.00/sh−3,750$93,750→ 10,700 total - Exercise/Conversion
Common Stock
2022-12-02$17.00/sh+1,875$31,875→ 12,575 total - Sale
Common Stock
2022-12-02$25.00/sh−1,875$46,875→ 10,700 total - Exercise/Conversion
Stock Option Right to Buy
2022-12-02−3,750→ 182,625 totalExercise: $7.03Exp: 2031-02-02→ Common Stock (3,750 underlying) - Exercise/Conversion
Stock Option Right to Buy
2022-12-02−1,875→ 71,688 totalExercise: $17.00Exp: 2031-04-22→ Common stock (1,875 underlying)
Footnotes (4)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 6,700 RSUs.
- [F3]The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
- [F4]The stock option vests in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.